Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Change in Receivables: 2021-2022

Historic Change in Receivables for Solid Biosciences (SLDB) over the last 2 years, with Dec 2022 value amounting to -$110,000.

  • Solid Biosciences' Change in Receivables fell 333.33% to -$14,000 in Q2 2022 from the same period last year, while for Jun 2022 it was -$286,000, marking a year-over-year change of. This contributed to the annual value of -$110,000 for FY2022, which is 200.00% down from last year.
  • As of FY2022, Solid Biosciences' Change in Receivables stood at -$110,000, which was down 200.00% from $110,000 recorded in FY2021.
  • Solid Biosciences' 5-year Change in Receivables high stood at $110,000 for FY2021, and its period low was -$110,000 during FY2022.
  • Moreover, its 2-year median value for Change in Receivables was $0 (2021), whereas its average is $0.
  • Data for Solid Biosciences' Change in Receivables shows a maximum YoY slumped of 200.00% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows Solid Biosciences' Change in Receivables stood at $110,000 in 2021, then plummeted by 200.00% to -$110,000 in 2022.